Chargement en cours...

Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context

Abstract Background Biomarkers such as amyloid imaging are increasingly used for diagnosis in the early stages of Alzheimer’s disease. Very few studies have examined this from the perspective of the patient. To date, there is only limited evidence about how patients experience and value disclosure i...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Gwendolien Vanderschaeghe, Jolien Schaeverbeke, Rose Bruffaerts, Rik Vandenberghe, Kris Dierickx
Format: Artigo
Langue:Inglês
Publié: BMC 2017-12-01
Collection:Alzheimer’s Research & Therapy
Sujets:
Accès en ligne:http://link.springer.com/article/10.1186/s13195-017-0321-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!